Full-Time

Actuary - Commercial Large Group Trend & Rate Review

Posted on 11/15/2025

Deadline 11/28/25
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$92.7k - $203.9k/yr

+ Bonus + Commission + Short-term Incentive

Company Historically Provides H1B Sponsorship

Chicago, IL, USA + 3 more

More locations: Ambler, PA, USA | Hartford, CT, USA | Atlanta, GA, USA

In Person

Category
Finance & Banking (1)
Required Skills
Sales
Data Analysis
Requirements
  • Bachelor's degree along with 3+ years of actuarial experience
  • ASA (Associate of the Society of Actuaries) designation preferred (or close to ASA)
  • Strong technical, analytical, and financial skills
  • Excellent verbal and written communication skills
  • Ability to think creatively and use multiple data sources to assess and develop business strategies
  • Ability to collaborate with experts from other teams to better understand issues/drivers and how/why the impact may differ by line of business
  • Bachelor's degree or equivalent experience
Responsibilities
  • Build out trend analytics, documentation, and communication to support market actuaries in assumption setting during the large group rate review
  • Lead continuous improvement and education as it relates to trend setting
  • Take learnings from various internal discussions related to trend and communicate those learnings to our broader large group pricing actuarial team
  • Seek out external resources to help understand macro drivers of trend
  • Participate as a critical team member to help coordinate the National Large Group Rate Review process
  • Provide valuable feedback on the Rate Review process to help develop and implement best practices for future cycles including but not limited to the trend setting process
  • Support the Central Region as an actuarial subject matter expert for South Central (TX, OK, NM) markets
  • Collaborate with the Plan President, Sales, Finance, Underwriting, Network, Contracting, and Product to develop market specific growth strategies while maintaining enterprise alignment
  • Proactively monitor financial performance and provide observations/insights into deep dives
  • Participate in the Implementation and Forecasting/Budget discussions
  • Oversee the Large Group Rate Filings/DOI objections when applicable
  • Takes accountability to ensure market specific requests and deliverables are met in a timely and responsive manner
  • Meet with the market to discuss technical results including but not limited to rate actions, trend and prior carrier relativity factors, and area factors
  • Demonstrate understanding of complex actuarial functions as well as the market specific dynamics including the competitive landscape
  • Build and facilitate creation of initiatives to drive down cost structure
  • Take full ownership of complex assignments and act as the trusted lead for the market
  • Communicate actuarial findings to business partners
  • Anticipate the market’s needs and be able to influence and further recommend corrective courses of action to maintain profitable growth
  • Demonstrate leadership that fosters and supports a strong team of individual contributors
  • Support actuarial and underwriting functions by applying quantitative skills and analytical methods
  • Demonstrated understanding of complex actuarial functions and market dynamics
  • Build out trend analytics, documentation, and communication to support market actuaries in assumption setting during the large group rate review
Desired Qualifications
  • FSA (Fellow of the Society of Actuaries) or actively working towards FSA designation
  • Ability to thrive in a constantly evolving environment with competing priorities and deadlines
  • Ability to collaborate with key stakeholders to formulate recommendations and course of actions

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Simplify Jobs

Simplify's Take

What believers are saying

  • AI call-center automation can reduce service costs and speed resolutions.
  • Biosimilar formulary shifts should improve specialty-drug economics from July 2026.
  • Improving medical-cost forecasting is lifting Aetna margins and guidance.

What critics are saying

  • UnitedHealth's integrated model intensifies pricing pressure on Aetna and Caremark.
  • Medicare Advantage cost inflation can quickly erase recent margin recovery.
  • PBM regulation threatens spread pricing, rebates, and formulary leverage.

What makes CVS Health unique

  • CVS combines Aetna insurance, Caremark PBM, and retail pharmacies.
  • Its 100 million-plus engagement base supports cross-business care coordination.
  • Technology partnerships deepen personalization across pharmacy and health-plan workflows.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at CVS Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

PR Newswire
Mar 30th, 2026
CVS opens first pharmacy-only location in Chicago, plans nearly 20 this year

CVS Health has opened its first pharmacy-only location in Chicago, part of plans to launch nearly 20 such sites across the US this year. The 3,000-square-foot store at 2628 West Pershing Road features a full-service pharmacy with selected over-the-counter products. The pharmacy-only format is designed to increase access to medications, immunizations and pharmacist consultations in underserved communities. Additional locations are planned for Houston, Roxbury, Detroit and Brooklyn in 2026, alongside more than 40 traditional CVS Pharmacy stores. The move responds to consumer preferences, with CVS's 2025 research showing 80% of patients prefer face-to-face pharmacy care and 48% would switch pharmacies if limited to digital-only options. The company opened its first pharmacy-only site in Birmingham, Alabama, late last year.

Yahoo Finance
Mar 26th, 2026
CVS settles FTC insulin pricing probe as regulatory scrutiny of pharmacy benefit manager intensifies

CVS Health has reached a proposed settlement with the Federal Trade Commission over insulin pricing practices at its Caremark pharmacy benefit manager unit. The company also declared a quarterly dividend of $0.665 per share, payable on 4 May 2026. The settlement places CVS's pharmacy benefit management model under increased regulatory scrutiny regarding drug cost transparency. The company's investment narrative centres on its integrated model across insurance, pharmacy and care delivery, with near-term focus on restoring profitability in healthcare delivery and PBM services. CVS recently appointed former Elevance Health CFO John E. Gallina to its board as an audit committee financial expert. The company's narrative projects $445.5 billion revenue and $10.2 billion earnings by 2029, implying a fair value of $96.50 per share.

Yahoo Finance
Mar 23rd, 2026
Bernstein upgrades CVS Health to Outperform with $94 price target amid Medicare Advantage turnaround

Bernstein analyst Lance Wilkes upgraded CVS Health to "Outperform" from "Market Perform" on 12 March, raising the price target to $94 from $91. The upgrade reflects the company's attractive exposure to the Medicare Advantage turnaround and expectations of stable earnings in its pharmacy and pharmacy benefit manager businesses following reforms. Wilkes cited the PBM bill passage and the Federal Trade Commission settlement with Cigna as clearing events for the stock. Separately, CVS Health announced a strategic partnership with Google Cloud focused on reimagining healthcare experiences through its new health technology subsidiary, Health100, which will offer AI-powered healthcare services. CVS Health operates as a diversified healthcare company combining insurance, pharmacy benefit management, retail pharmacies and clinical services across the United States.

Yahoo Finance
Mar 13th, 2026
CVS Health's Aetna unit pays $117.7M to settle Medicare Advantage fraud allegations

Aetna, a CVS Health subsidiary, has agreed to pay $117.7 million to the US Department of Justice to settle allegations that it submitted inaccurate diagnosis codes for Medicare Advantage members to increase reimbursements. The settlement resolves longstanding False Claims Act allegations related to the Medicare Advantage programme. CVS Health shares recently closed at $76.07, down 5.1% year-to-date, though up 20.1% over the past year. The settlement is material for the company, which has thin net margins of 0.4% and debt not well covered by operating cash flow. The agreement highlights compliance risks in CVS Health's government-facing insurance operations, a central part of its Medicare Advantage business. Analysts' average target price stands at $96.50, approximately 27% above current levels.

Yahoo Finance
Mar 7th, 2026
Alphabet faces wrongful death lawsuit over Gemini AI chatbot while expanding healthcare partnership with CVS

Alphabet faces a wrongful death lawsuit alleging its Gemini AI chatbot contributed to a user's suicide, reportedly the first legal case directly linking Google's AI tools to a death. Simultaneously, the company announced a healthcare AI partnership with CVS Health focused on a real-time consumer engagement platform. The contrasting developments underscore Alphabet's expanding role in high-stakes sectors. The CVS collaboration integrates Gemini into Health100, a platform handling personal interactions across insurers, pharmacies and care providers. Meanwhile, the lawsuit tests whether conversational AI design and crisis protocols carry a duty of care, even outside formal healthcare settings. For investors, the key questions centre on how Alphabet manages legal risk, establishes guardrails and navigates regulatory oversight as its AI tools penetrate sectors requiring heightened safety and compliance standards.

INACTIVE